Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

T. Matsuyama(Amgen (Canada)), Tohru Kimura(University of Toronto), Motoo Kitagawa(Osaka University), Klaus Pfeffer(Amgen (Canada)), Takatoshi Kawakami(Osaka University), Nobumasa Watanabe(Osaka University), Thomas M. Kündig(Ontario Institute for Cancer Research), Ryuichi Amakawa(Ontario Institute for Cancer Research), Kenji Kishihara(Ontario Institute for Cancer Research), Andrew Wakeham(Ontario Institute for Cancer Research), Julia M. Potter(University of Toronto), Caren Furlonger(Ontario Institute for Cancer Research), A. Narendran(University of Toronto), Haruhiko Suzuki(Ontario Institute for Cancer Research), Pamela S. Ohashi(University of Toronto), Christopher J. Paige(Ontario Institute for Cancer Research), Tadatsugu Taniguchi(Osaka University), Tak W. Mak(Amgen (Canada))
Cell
October 1, 1993
10.1016/s0092-8674(05)80086-8
Cited by 643

Abstract

Related Papers

The <i>in vitro</i> development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium
Thomas Doetschman, Harald Eistetter, Margot Katz et al.|Development|1985|2k
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Maarten Zijlstra, Mark Bix, Neil E. Simister et al.|Nature|1990|1k
Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system.
Nobuyuki Tanaka, Toshifumi Kawakami, Takeaki Taniguchi|Molecular and Cellular Biology|1993|408
Lymphocytic Choriomeningitis Virus
|Unknown|2016|405
Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated
Hisashi Harada, Keith R. Willison, Jun Sakakibara et al.|Cell|1990|379